Search Results 41-50 of 21202 for anti-TNF drugs

  1. Tofacitinib is first oral medication approved for use in treating moderate to severe ulcerative colitis - Mayo Clinic

    "It also appears to be efficacious in both the anti-TNF-exposed and anti-TNF-naive populations. So this will be a welcome addition to our armamentarium of ...

  2. Behcet's disease - Diagnosis and treatment - Mayo Clinic

    Examples include infliximab (Remicade) and adalimumab (Humira). Side effects might include headache, skin rash and an increased risk of infections. Request an ...

  3. Juvenile idiopathic arthritis - Diagnosis and treatment - Mayo Clinic

    ... (TNF) blockers, such as etanercept (Enbrel, Erelzi, Eticovo), adalimumab (Humira), golimumab (Simponi) and infliximab (Remicade, Inflectra, others). These ...

  4. Etanercept-Szzs (Subcutaneous Route) Proper Use - Mayo Clinic

    This medicine comes with a Medication Guide and patient instructions. Read and follow the instructions carefully. Ask your doctor if you have any questions. If ...

  5. Etanercept (Subcutaneous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  6. Adalimumab-Aacf (Subcutaneous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  7. Adalimumab-Adaz (Subcutaneous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  8. Adalimumab-Bwwd (Subcutaneous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  9. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy - Mayo Clinic

    ... Anti-TNF Therapy. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview. Tab ...

  10. Adalimumab-Fkjp (Subcutaneous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...